Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

Secure 2.0 brought forth a lot of changes. Here's how it can change your 401(k) strategy and what to do about it.

One of the most anticipated Formula 1 races of the year is approaching. The Monaco Grand Prix, which takes place on the narrow, winding streets of Monte Carlo, will take place on Sunday, June 7. The ...

The Tadpole submarine is an excellent way to explore the depths of Subnautica 2. It allows you to dive deep without risking running out of air, and also protects against hazardous heat conditions.

DIYer and woodworker April Wilkerson builds a giant 10-foot wooden sign for a custom project. What the budget tax reforms mean for rents, housing prices and supply Victorian emergency department nurse ...

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...

Public Accounts Committee (PAC) of Parliament says it has resolved to summon the Malawi Revenue Authority (MRA) to clarify whether taxes were paid in the Amaryllis Hotel sale deal. PAC chairperson ...

With the limited-edition U.S. passports featuring President Donald Trump's image rolling out this summer, some are wondering whether it'll become the default version of the travel document. The U.S.

You got approved for the MRA grant. S$20,000 in government funding to market your business overseas. So what do you do with it? If you're like most Singapore SMEs, you book a booth at an overseas ...

Artificial intelligence is not just a buzzword anymore. It is actively running core business operations across almost every industry. But consider what happens when an algorithm denies a loan ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...